Vera Therapeutics to Host ASN Kidney Week Investor Webcast and Third Quarter 2026 Financial Results Conference Webcast

$VERAPress releaseOct 20, 2026, 8:00 AM ETRead the release

Vera Therapeutics announced two investor webcasts: an October 22 session at 4:30 p.m. ET to discuss final ORIGIN 3 efficacy results for TRUTAKNA in IgA nephropathy, presented as a late-breaking oral at ASN Kidney Week 2026. A second webcast on November 5 at 4:30 p.m. ET will cover Q3 2026 financial results and business updates.

AI analysis

Red flags1 · Pro

The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.

Upgrade to Pro · $49/mo billed annually

AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.